|
|
Volumn 298, Issue 12, 2007, Pages 1385-1386
|
|
Studies point way to new therapeutic prospects for muscular dystrophy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DYSTROPHIN;
FIBRILLIN 1;
GENE PRODUCT;
GENTAMICIN;
LOSARTAN;
NEW DRUG;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;
PREDNISONE;
PTC 124;
TRANSFORMING GROWTH FACTOR BETA;
UNCLASSIFIED DRUG;
BEHAVIOR CHANGE;
CATARACT;
DRUG DOSE REGIMEN;
DRUG MECHANISM;
DRUG RESEARCH;
DUCHENNE MUSCULAR DYSTROPHY;
FRACTURE;
GENDER;
GENE EXPRESSION;
GENE MUTATION;
GENETIC LINKAGE;
HUMAN;
MARFAN SYNDROME;
MUSCLE REGENERATION;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT RESPONSE;
WEIGHT GAIN;
|
|
EID: 34748821964
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.298.12.1385 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|